Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study
Published Online: 2012-10-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Alfred D van het Schip•Bernard A Zonnenberg•Johannes FW Nijsen•Maarten AD Vente•Maarten LJ Smits•Marnix GEH Lam•Maurice AAJ van den Bosch•Willem PTM Mali
